BIOLOGICS
In an earlier blog post, I collected predictions on what impacts Donald Trump’s second presidential term would have on the biotech and pharmaceutical industries. This is a follow-up to that post, two months into the new administration. (Please note that this post does...
ET CETERA
Recombinant Serratia marcescens nuclease is frequently employed in contemporary downstream processing of viral and protein-based biopharmaceuticals. The enzyme was first isolated from S. marcescens, a bacilliform Gram-negative bacterium that was discovered in 1819. As...
ET CETERA
Ionic strength is a measure of the concentration of dissociated ions dissolved in a polar solvent; in the context of the life sciences, this almost always means aqueous solutions. The two most common dimensions used to express ionic strength are the same as those used...
ET CETERA
Hybridomas are cell lines historically used in the production of monoclonal antibodies. Mammals such as mice are immunized with an antigen of interest, and their antibody-producing B lymphocytes are harvested. The lymphocytes are fused with immortalized myeloma cells...
NEWS
On Monday, Donald J. Trump was inaugurated as the 47th U.S. president, leading many in the biotech and pharmaceutical sectors to speculate on what impacts the second Trump administration will have on their industries. Back in December, an article in Biospace by...
